Rebecca Watson
Director of Preclinical Safety, Novartis Biomedical Research
- Role
- Director, Preclinical Safety at Novartis
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Rebecca Watson
Diligent, motivated toxicologist with >20 years industry experience in drug development and consulting. Strong organizational, technical, and interpersonal skills. Key capabilities include:• Expertise in the conduct of general toxicology, TK, and developmental/reproductive toxicology studies with small and large molecule drug candidates as per GLP/OECH/ICH/EPA guidelines• Regulatory document preparation (IND, NDA, MAA, CTD, investigator brochures)• Preparation of risk assessment documents evaluating impacts of drug impurities and leachables; determines permissible daily exposure limits for manufacturing facilities• CRO selection and monitoring for toxicology, DMPK, and investigational studies• Collaboration with multidisciplinary groups, including CMC, clinical, and DMPK representatives• Risk assessment of pharmaceuticals, agricultural chemicals, and environmental pollutants• Areas of scientific expertise include cancer research, epigenetics, and developmental/reproductive toxicology
Experience
Director, Preclinical Safety
Feb 2020 — Present · Cambridge, MA, US
Education
Michigan State University
Ph.D, Pharmacology and Toxicology
1999 — 2004
Cornell University
B.S, Genetics and Development
1994 — 1998
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.